Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Mammograms May Also Reveal Hidden Heart Disease Risk, Study Finds

TUESDAY, March 10, 2026 A routine mammogram may reveal more than just signs of breast cancer. New research suggests the scans could also help docs spot early wa

Raw Oysters and Clams Recalled After Norovirus-Like Illness Outbreak in Washington

TUESDAY, March 10, 2026 Health officials in Washington state have temporarily shut down shellfish harvesting in Drayton Harbor after several folks became sick f

Poor Childhood Oral Health Linked to Atherosclerotic CVD in Adulthood

Poor childhood oral health is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) in adulthood, according to a study published

Auditory Hyperresponsivity Via Neural Pathways Seen in Chronic Back Pain

Chronic back pain (CBP) is associated with pronounced auditory hyperresponsivity via modality-specific and modality-general neural pathways, according to a stud

Ocular Motor Control, Cognitive Performance Linked After Mild TBI

For veterans with chronic mild traumatic brain injury (mTBI), ocular motor control and cognitive performance are persistent coexisting problems, according to a

Aggression in Adolescence Predicts Advanced Biologic Aging by Age 30 Years

Higher levels of aggression in early adolescence predict more advanced biological aging by age 30 years, according to a study published online March 5 in Health

Drop in Daytime Activity Patterns Precedes Disability Worsening in MS

For people with multiple sclerosis (PwMS), within-person reductions in daytime activity patterns precede clinical disability worsening, according to a study pub

Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma

Bristol Myers Squibb (NYSE BMY) today announced positive interim Phase 3 results from the SUCCESSOR-2 study (NCT05552976). In the trial, oral mezigdomide in com

Novo Nordisk Expands U.S. Patient Access to FDA-Approved Semaglutide Medicines Through Hims & Hers in Response to a Shift in Their U.S. GLP-1 Business Model

Plainsboro, NJ, US and Bagsv rd, Denmark, 09 March 2026 Novo Nordisk today announced it has reached an agreement with telehealth company Hims Hers that will tak

Ipsen Voluntarily Withdraws Tazverik (tazemetostat) in Follicular Lymphoma and Epithelioid Sarcoma

PARIS, FRANCE, 09 March 2026 Ipsen (Euronext IPN ADR IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from a

Popular Keywords